Boston Scientific BSX MedSurg — Net Sales

Other segment segments

Similar metrics at other companies

SYKMedSurg and Neurotechnology: — Net Sales

$3.21B+4.9%

CENTPet — Net Sales

$476.84M+5.1%

CNHNet Sales — Net Sales

$2.6B+0.6%

GISPet — Net Sales

$746.6M+5.8%

OTISNew Equipment — Net Sales

$1.28B+0.2%

CLPet Nutrition — Net Sales

$1.2B—

FAQ

What is Boston Scientific's medsurg — net sales?

Boston Scientific (BSX) reported medsurg — net sales of $1.82B in Q2 2026.

How has Boston Scientific's medsurg — net sales changed year-over-year?

Boston Scientific's medsurg — net sales increased by 5.9% year-over-year, from $1.72B to $1.82B.

What is the long-term trend for Boston Scientific's medsurg — net sales?

Over 4 years (2021 to 2025), Boston Scientific's medsurg — net sales has grown at a 10.2% compound annual growth rate (CAGR), from $4.63B to $6.82B.

What does medsurg — net sales mean?

The total revenue generated by the MedSurg segment from the sale of medical devices and related services, net of returns, allowances, and discounts. This is the primary indicator of the segment's market demand and top-line growth performance.